action that evaluates patent validity. An economic incentive to challenge weak patents should also be introduced in Canada …

community that shares in the financing of pharmaceutical R&D under the current global patent system. In this Commentary, we … international burden-sharing system. In the area of patent legislation that relates to pharmaceuticals, the federal government …

This essay is the introduction to a forthcoming volume entitled, Regulating Innovation: Competition Policy and Patent … relationship between regulation - both through competition policy and patent law - and innovation, and the corresponding …

associated with Food and Drug Administration (FDA)-mandated clinical trials of new drugs. But the relationship between the patent …

other types of mechanisms in regulatory laws that provide patent-like protection or further strengthen existing patent … drug companies: data exclusivity and patent linkage. As noted in earlier chapters (separately posted on SSRN), not all … competition, a thorough understanding of these requirements (as well as how they intersect with patent protection) is important to …

Patent protection for sev ... …